NASDAQ:ACCD
Accolade Inc. Stock News
$7.48
+0.150 (+2.05%)
At Close: May 17, 2024
Accolade Inc CEO Rajeev Singh Sells 1,553 Shares: An Insider Sell Analysis
10:08pm, Thursday, 25'th May 2023
On May 23, 2023, Rajeev Singh, the CEO of Accolade Inc ( ACCD , Financial), sold 1,553 shares of the company. This article will provide an analysis of this insider sell, the relationship between insid
Accolade Inc CEO Rajeev Singh Sells 1,456 Shares
10:07pm, Thursday, 25'th May 2023
On May 24, 2023, Rajeev Singh, the CEO of Accolade Inc ( ACCD , Financial), sold 1,456 shares of the company's stock. This move comes amidst a year of both buying and selling activity for Singh, who h
Accolade (ACCD) Upgraded to Buy: What Does It Mean for the Stock?
01:13pm, Wednesday, 24'th May 2023
Accolade (ACCD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In May - Bio-Rad Laboratories (NYSE:BIO), Accolade (NASDAQ:ACCD)
08:00am, Thursday, 11'th May 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Accolade, Inc. (ACCD) Q4 2023 Earnings Call Transcript
11:11pm, Thursday, 27'th Apr 2023
Accolade, Inc. (ACCD) Q4 2023 Earnings Call Transcript.
Accolade (ACCD) Reports Q4 Loss, Misses Revenue Estimates
07:01pm, Thursday, 27'th Apr 2023
Accolade (ACCD) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to loss of $0.27 per share a year ago.
Accolade to Webcast Analyst Day on May 8, 2023
04:05pm, Monday, 24'th Apr 2023
SEATTLE, April 24, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will host an Analyst Day at the Wynn Las Vega
Accolade to Announce Fiscal Fourth Quarter 2023 Financial Results
08:00am, Tuesday, 11'th Apr 2023
SEATTLE, April 11, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will release fiscal fourth quarter 2023 finan
Healthcare company Accolade lays off workers and closes offices
08:32pm, Monday, 06'th Mar 2023
Seattle and Philadelphia area-based primary healthcare company Accolade is cutting its workforce and closing or reducing some facilities, according to a recent regulatory filing.
Why Shares of Accolade Soared This Week
12:39pm, Friday, 13'th Jan 2023
Strong revenue growth and encouraging guidance pushed the stock up.
Accolade, Inc. (ACCD) Q3 2023 Earnings Call Transcript
09:58pm, Monday, 09'th Jan 2023
Accolade, Inc. (NASDAQ:ACCD ) Q3 2023 Earnings Conference Call January 9, 2023 4:30 PM ET Company Participants Rajeev Singh - Chief Executive Officer Steve Barnes - Chief Financial Officer Shantanu Nu
Accolade (ACCD) Reports Q3 Loss, Tops Revenue Estimates
06:48pm, Monday, 09'th Jan 2023
Accolade (ACCD) delivered earnings and revenue surprises of 8.20% and 4.43%, respectively, for the quarter ended November 2022. Do the numbers hold clues to what lies ahead for the stock?
Accolade to Announce Fiscal Third Quarter 2023 Financial Results
08:00am, Tuesday, 20'th Dec 2022
SEATTLE, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will release fiscal third quarter 2023 financi
Accolade Inc. (ACCD) Q2 2023 Results - Earnings Call Transcript
10:39pm, Thursday, 06'th Oct 2022
Accolade Inc. (NASDAQ:ACCD ) Q2 2023 Earnings Conference Call October 6, 2022 4:30 PM ET Company Participants Rajeev Singh - Chief Executive Officer Steve Barnes - Chief Financial Officer Shantanu Nun
Accolade (ACCD) Reports Q2 Loss, Tops Revenue Estimates
06:48pm, Thursday, 06'th Oct 2022
Accolade (ACCD) delivered earnings and revenue surprises of 7.04% and 5.68%, respectively, for the quarter ended August 2022. Do the numbers hold clues to what lies ahead for the stock?